Skip to main content

Table 1 Patient characteristics (n = 293)

From: Plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) and early mortality risk among patients enrolling for antiretroviral treatment in South Africa

Age median (IQR), years

33(29–38)

Female sex

205(70)

Median (IQR) CD4 cell count

47(22–72)

WHO Stage

 

1/2

32(11)

3

150(51)

4

111(38)

Viral load > 105 copies/ml

149(51)

Tuberculosis,

 

   Present at enrolment

80(27)

   Developed during ART

47(16)

Median (IQR) duration

 

follow up (days)

145(139–173)

Outcome

 

   Alive on ART

218(74)

   Deaths pre or during ART

39(13)

   Non-death losses

36(12)

  1. Baseline characteristics and outcome of patients enrolling in the antiretroviral treatment (ART) programme who were included in the analysis. Unless otherwise stated, values are numbers (%) of patients.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us